Haemoglobin fluctuations in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa

被引：0

作者：

Walker, R.

Pussell, B. A.

机构：

[1] Royal Melbourne Hosp, Parkville, Vic 3050, Australia

[2] Prince Wales Hosp, Randwick, NSW 2031, Australia

来源：

VALUE IN HEALTH | 2007年 / 10卷 / 03期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A103 / A103

页数：1

共 50 条

[1] Fluctuations in haemoglobin levels in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa
Walker, Rowan
Pussell, Bruce A.
NEPHROLOGY, 2007, 12 (05) : 448 - 451
[2] Fluctuations in haemoglobin levels in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa
Walker, Rowan
Pussell, Bruce
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 348 - 348
[3] THE DOSE EQUIVALENT RATIO FOR INTRAVENOUS EPOETIN ALFA AND INTRAVENOUS DARBEPOETIN ALFA USED IN AUSTRALIAN HAEMODIALYSIS PATIENTS
Walker, R.
Pussell, B.
NEPHROLOGY, 2006, 11 : A17 - A17
[4] Australian haemodialysis patients on intravenous epoetin alfa or intravenous darbopoetin alfa: How do they compare?
Pussell, Bruce A.
Walker, Rowan
NEPHROLOGY, 2007, 12 (02) : 126 - 129
[5] An audit comparing subcutaneous epoetin alfa to intravenous darbepoetin alfa in chronic hemodialysis patients
Summers, S
Winnett, G
Matijevic, A
Carmichael, D
Almond, M
DIALYSIS & TRANSPLANTATION, 2005, 34 (06) : 358 - +
[6] Haemoglobin response to subcutaneous versus intravenous epoetin alfa administration in iron-replete haemodialysis patients
Leikis, MJ
Kent, AB
Becker, GJ
McMahon, LP
NEPHROLOGY, 2004, 9 (03) : 153 - 160
[7] Intravenous Aranesp® (Darbepoetin Alfa) in the management of anaemia of haemodialysis patients previously receiving subcutaneous erythropoietin (rHuEPO).
Jenkins, KJ
Bennett, LI
Monk, A
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 459A - 459A
[8] Comparison of doses of epoetin alfa and darbepoetin alfa required for maintenance of haemoglobin levels
Pussell, BA
Walker, R
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V258 - V259
[9] Population pharmacokinetics of darbepoetin alfa in haemodialysis and peritoneal dialysis patients after intravenous administration
Takama, Hirotaka
Tanaka, Hideji
Nakashima, Daisuke
Ogata, Hiroyasu
Uchida, Eiji
Akizawa, Tadao
Koshikawa, Shozo
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) : 300 - 309
[10] Comparison of anemia treatment outcomes in patients with cancer receiving epoetin alfa and darbepoetin alfa.
Fahrbach, KR
Frame, D
Scheye, R
Fastenau, JM
Drielick, M
Piech, CT
Nalysnyk, L
BLOOD, 2003, 102 (11) : 510B - 511B

← 1 2 3 4 5 →